Oral ketamine reduces the experience of stress in people with chronic suicidality
Journal of Affective Disorders(2022)
摘要
•Oral ketamine reduced self-reported stress in people with suicidality.•Six, weekly doses resulted in stress symptoms reducing to sub-clinical levels.•Stress symptoms re-emerged after 4 weeks of no ketamine treatment.•However, suicidality responders had a maintained stress reduction at follow-up.•Exploration of neurobiology of stress response to oral ketamine is warranted.
更多查看译文
关键词
Ketamine,Stress,Suicidality,Open label
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要